Expertise in
12
conditions

Boris Bienvenu

CHU De Caen
Caen, FR 
Expertise in
12
conditions
CHU De Caen
Caen, FR 

Overview

Boris Bienvenu practices practicing medicine in Caen, France.

Mr. Bienvenu is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Vasculitis, Polyarteritis Nodosa, Necrotizing Vasculitis, and Temporal Arteritis.

He is actively involved in clinical research, co-authoring 118 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

CHU de Caen
Caen, 14000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)
Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Drug
Study Drugs: Steroid, Cyclophosphamide, Rituximab
Study Phase: Phase 3
Prospective, Sequential Multiple Assignment, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia
Prospective, Sequential Multiple Assignment, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drugs: Methotrexate, Cyclophosphamide
Study Phase: Phase 2
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
Enrollment Status: Terminated
Publish Date: October 26, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

118 Total Publications

Significance of T2 hyperintensity in extraocular muscle hypertrophy.
Significance of T2 hyperintensity in extraocular muscle hypertrophy.
Journal: Journal francais d'ophtalmologie
Published: January 30, 2025

Frequently Asked Questions about Boris Bienvenu

Is Boris Bienvenu a top-rated expert for Vasculitis?

MediFind is an objective health platform that identifies experts based on real-world data. Boris Bienvenu is classified as an Elite expert for Vasculitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Boris Bienvenu participate in research or clinical trials?

Yes. Boris Bienvenu has published 118 articles and abstracts on conditions like Vasculitis. You can view a list of Boris Bienvenu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bienvenu's expertise for a condition
ConditionClose
View All 46 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile